Free Trial

Connect Biopharma (CNTB) Competitors

Connect Biopharma logo
$1.09 -0.05 (-4.08%)
Closing price 03:59 PM Eastern
Extended Trading
$1.12 +0.04 (+3.25%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CNTB vs. PRQR, NBTX, YMAB, IMAB, CRDF, INBX, MDWD, SOPH, MNPR, and SCPH

Should you be buying Connect Biopharma stock or one of its competitors? The main competitors of Connect Biopharma include ProQR Therapeutics (PRQR), Nanobiotix (NBTX), Y-mAbs Therapeutics (YMAB), I-Mab (IMAB), Cardiff Oncology (CRDF), Inhibrx Biosciences (INBX), MediWound (MDWD), SOPHiA GENETICS (SOPH), Monopar Therapeutics (MNPR), and scPharmaceuticals (SCPH). These companies are all part of the "pharmaceutical products" industry.

Connect Biopharma vs. Its Competitors

Connect Biopharma (NASDAQ:CNTB) and ProQR Therapeutics (NASDAQ:PRQR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

Connect Biopharma has higher revenue and earnings than ProQR Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Connect Biopharma$26.03M2.32-$15.63MN/AN/A
ProQR Therapeutics$20.46M11.83-$30.04M-$0.35-6.57

Connect Biopharma has a beta of -0.2, meaning that its stock price is 120% less volatile than the S&P 500. Comparatively, ProQR Therapeutics has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500.

58.7% of Connect Biopharma shares are held by institutional investors. Comparatively, 32.7% of ProQR Therapeutics shares are held by institutional investors. 22.6% of Connect Biopharma shares are held by insiders. Comparatively, 8.4% of ProQR Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Connect Biopharma has a net margin of 0.00% compared to ProQR Therapeutics' net margin of -157.04%. Connect Biopharma's return on equity of 0.00% beat ProQR Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Connect BiopharmaN/A N/A N/A
ProQR Therapeutics -157.04%-53.49%-22.07%

Connect Biopharma currently has a consensus price target of $7.00, suggesting a potential upside of 543.03%. ProQR Therapeutics has a consensus price target of $8.00, suggesting a potential upside of 247.83%. Given Connect Biopharma's higher possible upside, analysts plainly believe Connect Biopharma is more favorable than ProQR Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Connect Biopharma
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
ProQR Therapeutics
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

In the previous week, ProQR Therapeutics had 1 more articles in the media than Connect Biopharma. MarketBeat recorded 4 mentions for ProQR Therapeutics and 3 mentions for Connect Biopharma. ProQR Therapeutics' average media sentiment score of 0.22 beat Connect Biopharma's score of -0.30 indicating that ProQR Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Connect Biopharma
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
ProQR Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Connect Biopharma beats ProQR Therapeutics on 8 of the 15 factors compared between the two stocks.

Get Connect Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNTB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNTB vs. The Competition

MetricConnect BiopharmaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$63.06M$2.90B$5.51B$8.96B
Dividend YieldN/A2.44%5.25%4.02%
P/E RatioN/A21.0128.0520.15
Price / Sales2.32294.68438.14127.85
Price / CashN/A41.8337.0657.97
Price / Book0.657.868.125.62
Net Income-$15.63M-$54.95M$3.16B$248.50M
7 Day Performance0.80%6.24%4.40%5.54%
1 Month Performance39.39%5.70%4.09%7.52%
1 Year Performance-16.26%8.08%34.53%22.06%

Connect Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNTB
Connect Biopharma
3.3157 of 5 stars
$1.09
-4.1%
$7.00
+543.0%
-12.7%$63.06M$26.03M0.00110News Coverage
High Trading Volume
PRQR
ProQR Therapeutics
2.1226 of 5 stars
$2.04
flat
$8.00
+292.2%
+32.5%$214.63M$20.46M-5.83180News Coverage
NBTX
Nanobiotix
2.2463 of 5 stars
$4.73
+4.4%
$8.00
+69.1%
+2.5%$213.34M$39.18M0.00100News Coverage
Positive News
Gap Up
YMAB
Y-mAbs Therapeutics
3.2647 of 5 stars
$4.51
-4.0%
$15.60
+245.9%
-62.7%$212.83M$87.68M-7.05150
IMAB
I-Mab
2.8948 of 5 stars
$2.42
-5.8%
$6.00
+147.9%
+41.0%$209.87M$3.89M0.00380News Coverage
Analyst Forecast
Gap Up
CRDF
Cardiff Oncology
1.6636 of 5 stars
$3.15
flat
$9.88
+213.5%
+77.5%$209.56M$680K-3.4220News Coverage
Analyst Forecast
INBX
Inhibrx Biosciences
1.7924 of 5 stars
$14.27
-1.1%
N/A+46.5%$208.89M$200K0.12166News Coverage
MDWD
MediWound
1.6096 of 5 stars
$19.37
+0.6%
$31.80
+64.2%
+0.1%$208.16M$20.22M-9.2780
SOPH
SOPHiA GENETICS
2.3769 of 5 stars
$3.10
+0.3%
$7.00
+125.8%
-21.2%$206.06M$65.17M-3.10520News Coverage
MNPR
Monopar Therapeutics
2.9596 of 5 stars
$35.78
+6.5%
$56.50
+57.9%
+940.0%$205.47MN/A-10.2810News Coverage
Analyst Forecast
Analyst Revision
Gap Up
SCPH
scPharmaceuticals
4.14 of 5 stars
$3.81
-1.6%
$14.00
+267.5%
-9.4%$204.30M$36.33M-1.9930

Related Companies and Tools


This page (NASDAQ:CNTB) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners